| ||
Name: n-[(2s)-4-(5-fluoropyrimidin-2-yl)-1-({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)butan-2-yl]-n-hydroxyformamide | ||
Formula: C19 H23 F4 N7 O5 S | ||
Weight: 537.488 | ||
SMILES: "ON(C=O)[CH](CCc1ncc(F)cn1)C[S](=O)(=O)N2CCN(CC2)c3ncc(OCC(F)(F)F)cn3" | ||
Spacial conformation based on PDB 4jp4 |
RESIDUE AZ4 59 CONECT C1 3 N1 O2 H1 CONECT C2 4 C3 C9 N1 H2 CONECT C3 4 C2 C4 H3 H4 CONECT O4 1 S1 CONECT O5 2 C16 C17 CONECT N6 2 C14 C15 CONECT C7 3 C8 C6 F1 CONECT C8 3 C7 N3 H5 CONECT C9 4 C2 S1 H6 H7 CONECT C10 4 C11 N4 H8 H9 CONECT C11 4 C10 N5 H10 H11 CONECT C12 4 C13 N5 H12 H13 CONECT C13 4 C12 N4 H14 H15 CONECT C14 3 N6 N5 N7 CONECT C15 3 N6 C16 H16 CONECT C16 3 O5 C15 C19 CONECT C19 3 C16 N7 H17 CONECT O1 2 N1 H18 CONECT N1 3 C1 C2 O1 CONECT O2 1 C1 CONECT C4 4 C3 C5 H19 H20 CONECT C5 3 C4 N2 N3 CONECT N2 2 C5 C6 CONECT C6 3 C7 N2 H21 CONECT F1 1 C7 CONECT N3 2 C8 C5 CONECT S1 4 O4 C9 O3 N4 CONECT O3 1 S1 CONECT N4 3 C10 C13 S1 CONECT N5 3 C11 C12 C14 CONECT C17 4 O5 C18 H22 H23 CONECT C18 4 C17 F2 F3 F4 CONECT F2 1 C18 CONECT F3 1 C18 CONECT F4 1 C18 CONECT N7 2 C14 C19 CONECT H1 1 C1 CONECT H2 1 C2 CONECT H3 1 C3 CONECT H4 1 C3 CONECT H5 1 C8 CONECT H6 1 C9 CONECT H7 1 C9 CONECT H8 1 C10 CONECT H9 1 C10 CONECT H10 1 C11 CONECT H11 1 C11 CONECT H12 1 C12 CONECT H13 1 C12 CONECT H14 1 C13 CONECT H15 1 C13 CONECT H16 1 C15 CONECT H17 1 C19 CONECT H18 1 O1 CONECT H19 1 C4 CONECT H20 1 C4 CONECT H21 1 C6 CONECT H22 1 C17 CONECT H23 1 C17 END HET AZ4 59 HETNAM AZ4 N-[(2S)-4-(5-fluoropyrimidin-2-yl)-1-({4-[5-(2,2,2-trif HETNAM 2 AZ4 luoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)buta HETNAM 3 AZ4 n-2-yl]-N-hydroxyformamide FORMUL AZ4 C19 H23 F4 N7 O5 S1
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|